Characteristics of SARS-CoV-2 and potential pharmacological treatment / Charakterystyka wirusa SARS-CoV-2 i potencjalne farmakologiczne sposoby leczenia.
Postepy Biochem
; 66(2): 83-90, 2020 05 09.
Artículo
en Polaco
| MEDLINE | ID: covidwho-689005
ABSTRACT
In December 2019 in Wuhan, China the first cases of previously unknown, coronaviral infection-induced pneumonia have been reported. The new virus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) was named after SARS-CoV due to their similarities and the disease caused by the pathogen is COVID-19 (Coronavirus Disease 2019). On 11 March 2020 WHO (World Health Organization) defined the rapidly increasing number of incidents of COVID-19 as a pandemic. In this review we will present recent information about the SARS-CoV-2 focusing on the origin, clinical picture, diagnostic methods, structure, replication cycle of SARS-CoV-2 and potential pharmaceutical measures against COVID-19.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Neumonía Viral
/
Infecciones por Coronavirus
/
Betacoronavirus
Tipo de estudio:
Estudios diagnósticos
/
Estudio observacional
/
Estudio pronóstico
Límite:
Humanos
País/Región como asunto:
Asia
Idioma:
Polaco
Revista:
Postepy Biochem
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS